Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Piribedil is a dopamine receptor agonist.1,2,3,4 It binds to dopamine D2, D3, and D4 receptors (IC50s = 1-1,000 nM in radioligand binding assays).1 Piribedil (1 and 10 mg/kg) enhances spontaneous object recognition in young adult rats and attenuates age-related memory impairments in the radial arm maze in mice.2 It reduces immobility time in the forced swim test in mice when administered at doses ranging from 0.63 to 10 mg/kg.3 Piribedil (0.3 mg/kg) decreases the number of premature and delayed responses in a response time test, indicating improved attentional function, in a rat model of Parkinson's disease induced by 6-OHDA (Item No. 25330) when administered in combination with L-DOPA (Item No. 13248).4
WARNING This product is not for human or veterinary use.
1. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study. Eur. J. Pharmacol. 313(1-2), 63-67 (1996).
2. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents. J. Psychopharmacol. 22(5), 511-521 (2008).
3. Antidepressant-
4. The dopamine agonist piribedil with L-